Gary D. Tollefson

Overview

Best Publications

• Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

  Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter

  1279
  Citations

• Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

  Gary D. Tollefson;Charles M. Beasley;Pierre V. Tran;Jamie S. Street

  1252
  Citations

• Olanzapine versus placebo and haloperidol: Acute phase results of the North American double-blind olanzapine trial

  Charles M Beasley;Gary Tollefson;Pierre Tran;Winston Satterlee

  1110
  Citations

• Antipsychotic drug effects on brain morphology in first-episode psychosis

  Jeffrey A. Lieberman;Jeffrey A. Lieberman;Gary D. Tollefson;Cecil Charles;Robert Zipursky

  955
  Citations

• Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders.

  Pierre V. Tran;Susan H. Hamilton;Amy J. Kuntz;Janet H. Potvin

  954
  Citations

• Olanzapine Versus Placebo in the Treatment of Acute Mania

  M. Tohen;T. M. Sanger;S. L. Mcelroy;G. D. Tollefson

  858
  Citations

• Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study

  Mauricio Tohen;Thomas G. Jacobs;Starr L. Grundy;Susan L. McElroy

  837
  Citations

• A novel augmentation strategy for treating resistant major depression.

  Richard C. Shelton;Gary D. Tollefson;Mauricio Tohen;Stephen Stahl

  827
  Citations

• Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: A double-blind, randomized, placebo-controlled trial

  Jamie S. Street;W. Scott Clark;Kimberley S. Gannon;Jeffrey L. Cummings

  800
  Citations

• Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease.

  Neil C. Bodick;Walter W. Offen;Allan I. Levey;Neal R. Cutler

  748
  Citations

• Neuropsychological Change in Early Phase Schizophrenia During 12 Months of Treatment With Olanzapine, Risperidone, or Haloperidol

  Scot E. Purdon;Barry D. W. Jones;Barry D. W. Jones;Emanuel Stip;Alan Labelle

  680
  Citations

• Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

  Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  619
  Citations

• Olanzapine versus placebo: results of a double-blind, fixed-dose olanzapine trial.

  Beasley Cm;Sanger T;Satterlee W;Tollefson G

  557
  Citations

• Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol

  Jeffrey A. Lieberman;Gary Tollefson;Mauricio Tohen;Alan I. Green

  532
  Citations

• Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.

  Bruce J. Kinon;Bruce R. Basson;Julie A. Gilmore;Gary D. Tollefson

  465
  Citations

• Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol

  Richard S E Keefe;Larry J Seidman;Bruce K Christensen;Robert M Hamer

  438
  Citations

• A Multicenter Investigation of Fixed-Dose Fluoxetine in the Treatment of Obsessive-compulsive Disorder

  Gary D. Tollefson;Alvin H. Rampey;Janet H. Potvin;Michael A. Jenike

  434
  Citations

• Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

  Charles M Beasley;Susan H Hamilton;Ann Marie Crawford;Mary Anne Dellva

  416
  Citations

• Rational Design of a Combination Medication for the Treatment of Obesity

  Frank L. Greenway;M.J. Whitehouse;Maria Guttadauria;James W. Anderson

  414
  Citations

• Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.

  Tollefson Gd;Sanger Tm

  393
  Citations